RxNorm Semantic Concepts Index - 314
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "314".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 314 | Ca^2+^-transporting adenosine triphosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314 | Ca^2+^-transporting adenosine triphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 314 | Ca^2+^-transporting adenosine triphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 314 | Ca^2+^-transporting adenosine triphosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314000 | glyBURIDE 1.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314002 | gramicidin 0.025 MG/ML / neomycin 2.5 MG/ML / polymyxin B 5000 UNT/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314003 | menthol / methyl salicylate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 314004 | guaifenesin 180 MG / theophylline 300 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314004 | guaifenesin 180 MG / theophylline 300 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314006 | glipiZIDE 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314007 | ganciclovir 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314007 | ganciclovir 250 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 314007 | ganciclovir 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314007 | ganciclovir 250 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 314008 | gosarelin acetate 10.8 MG Subcutaneous Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314008 | gosarelin acetate 10.8 MG Subcutaneous Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314008 | gosarelin acetate 10.8 MG Subcutaneous Drug Implant | Designated preferred name (PT) | YES | |
| RxCUI: 314008 | gosarelin acetate 10.8 MG Subcutaneous Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314008 | gosarelin acetate 10.8 MG Subcutaneous Drug Implant | Full form of descriptor (FN) | YES | |
| RxCUI: 314009 | gatifloxacin 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314009 | gatifloxacin 400 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314009 | gatifloxacin 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314009 | gatifloxacin 400 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314011 | witch hazel 0.5 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314012 | hydrocortisone 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314014 | hydroquinone 3.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314014 | hydroquinone 3.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314014 | hydroquinone 3.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314018 | reserpine 0.1 MG / hydroCHLOROthiazide 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314018 | reserpine 0.1 MG / hydroCHLOROthiazide 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314018 | reserpine 0.1 MG / hydroCHLOROthiazide 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314018 | reserpine 0.1 MG / hydroCHLOROthiazide 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314020 | HCTZ 100 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314020 | HCTZ 100 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314020 | HCTZ 100 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314021 | hydrocortisone 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314021 | hydrocortisone 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314021 | hydrocortisone 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314029 | triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314032 | halofantrine HCl 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314032 | halofantrine HCl 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314032 | halofantrine HCl 250 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314032 | halofantrine HCl 250 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314034 | haloperidol 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314034 | haloperidol 2 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314034 | haloperidol 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314034 | haloperidol 2 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314035 | haloperidol 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314035 | haloperidol 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314035 | haloperidol 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314035 | haloperidol 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314038 | insulin, protamine zinc, beef-pork 40 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314039 | isoetharine 0.34 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314040 | isosorbide dinitrate 40 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314040 | isosorbide dinitrate 40 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314040 | isosorbide dinitrate 40 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314040 | isosorbide dinitrate 40 MG Extended Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314040 | isosorbide dinitrate 40 MG Extended Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314041 | isoetharine 1.25 MG/ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314042 | isoetharine 2 MG/ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314043 | isoetharine 5 MG/ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314045 | ultralente insulin, human 100 UNT/ML Injectable Suspension [Humulin U Ultralente] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314045 | ultralente insulin, human 100 UNT/ML Injectable Suspension [Humulin U Ultralente] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314045 | ultralente insulin, human 100 UNT/ML Injectable Suspension [Humulin U Ultralente] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 314045 | ultralente insulin, human 100 UNT/ML Injectable Suspension [Humulin U Ultralente] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314047 | ibuprofen 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314047 | ibuprofen 50 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314047 | ibuprofen 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314047 | ibuprofen 50 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314050 | interferon alfa-2a 36000000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314055 | isosorbide dinitrate 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314055 | isosorbide dinitrate 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314055 | isosorbide dinitrate 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314055 | isosorbide dinitrate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314055 | isosorbide dinitrate 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314058 | ketoprofen 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314059 | ketoprofen 100 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314059 | ketoprofen 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314059 | ketoprofen 100 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314059 | ketoprofen 100 MG 24HR Extended Release Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 314059 | ketoprofen 100 MG 24HR Extended Release Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 314063 | lactose 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314063 | lactose 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314072 | latanoprost 0.005 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314075 | loxapine succinate 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314075 | loxapine succinate 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314075 | loxapine succinate 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314075 | loxapine succinate 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314075 | loxapine succinate 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314076 | lisinopril 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314076 | lisinopril 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314076 | lisinopril 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314076 | lisinopril 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314077 | lisinopril 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314077 | lisinopril 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314077 | lisinopril 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314077 | lisinopril 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314078 | loxapine succinate 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314078 | loxapine succinate 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314078 | loxapine succinate 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314078 | loxapine succinate 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314078 | loxapine succinate 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314079 | linezolid 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314079 | linezolid 400 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314079 | linezolid 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314079 | linezolid 400 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314080 | levoFLOXacin 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314081 | magaldrate 540 MG / simethicone 20 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314081 | magaldrate 540 MG / simethicone 20 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314087 | magnesium hydroxide 2400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314087 | magnesium hydroxide 2400 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314087 | magnesium hydroxide 2400 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314087 | magnesium hydroxide 2400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314087 | magnesium hydroxide 2400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314088 | methscopolamine bromide 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314088 | methscopolamine bromide 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314088 | methscopolamine bromide 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314088 | methscopolamine bromide 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314088 | methscopolamine bromide 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314092 | mesalamine 250 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314092 | mesalamine 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314092 | mesalamine 250 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314097 | menotropins 75 UNT Injection | British preferred term (PTGB) | YES | |
| RxCUI: 314097 | menotropins 75 UNT Injection | Designated preferred name (PT) | YES | |
| RxCUI: 314097 | menotropins 75 UNT Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 314099 | methylPREDNISolone 62.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314099 | methylPREDNISolone 62.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314099 | methylPREDNISolone 62.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314099 | methylPREDNISolone 62.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314099 | methylPREDNISolone 62.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 3141 | Dehydrocholic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 3141 | Dehydrocholic acid | Designated preferred name (PT) | NO | |
| RxCUI: 3141 | Dehydrocholic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 3141 | Dehydrocholic acid | Designated preferred name (PT) | NO | |
| RxCUI: 3141 | Dehydrocholic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 314106 | metroNIDAZOLE 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314106 | metroNIDAZOLE 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314106 | metroNIDAZOLE 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314106 | metroNIDAZOLE 250 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314106 | metroNIDAZOLE 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314107 | methyprylon 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314107 | methyprylon 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314108 | minocycline HCl 75 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314108 | minocycline HCl 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314108 | minocycline HCl 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314108 | minocycline HCl 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314108 | minocycline HCl 75 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314109 | methylTESTOSTERone 10 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314109 | methylTESTOSTERone 10 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314109 | methylTESTOSTERone 10 MG Sublingual Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314110 | methylTESTOSTERone 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314110 | methylTESTOSTERone 25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314110 | methylTESTOSTERone 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314110 | methylTESTOSTERone 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314110 | methylTESTOSTERone 25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314111 | mirtazapine 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314111 | mirtazapine 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314111 | mirtazapine 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314111 | mirtazapine 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314113 | magnesium oxide 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314113 | magnesium oxide 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314116 | niacin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314116 | niacin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314116 | niacin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314116 | niacin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314116 | niacin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314119 | nicotine polacrilex 2 MG Chewing Gum | Designated preferred name (PT) | YES | |
| RxCUI: 314119 | nicotine polacrilex 2 MG Chewing Gum | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314119 | nicotine polacrilex 2 MG Chewing Gum | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314119 | nicotine polacrilex 2 MG Chewing Gum | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314119 | nicotine polacrilex 2 MG Chewing Gum | Full form of descriptor (FN) | YES | |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314121 | nitroglycerin 1 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314122 | nitroglycerin 5 MG Sustained Release Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314124 | neomycin sulfate 40 MG / polymyxin B sulfate 200,000 UNT per mL Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314124 | neomycin sulfate 40 MG / polymyxin B sulfate 200,000 UNT per mL Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314131 | niacin 250 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314131 | niacin 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314131 | niacin 250 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314131 | niacin 250 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314131 | niacin 250 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314132 | NIFEdipine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314132 | NIFEdipine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314132 | NIFEdipine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314133 | nalmefene 0.1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314135 | naratriptan 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314135 | naratriptan 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314135 | naratriptan 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314135 | naratriptan 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314135 | naratriptan 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314136 | nonoxynol-9 8 % Vaginal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314136 | nonoxynol-9 8 % Vaginal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314136 | nonoxynol-9 8 % Vaginal Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314142 | nateglinide 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314142 | nateglinide 60 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314142 | nateglinide 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314142 | nateglinide 60 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314145 | oxtriphylline 400 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314145 | oxtriphylline 400 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314146 | ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314152 | octreotide 200 MCG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314152 | octreotide 200 MCG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314152 | octreotide 200 MCG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314152 | octreotide 200 MCG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314152 | octreotide 200 MCG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314153 | orlistat 120 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314153 | orlistat 120 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314153 | orlistat 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314153 | orlistat 120 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314154 | OLANZapine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314154 | OLANZapine 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314154 | OLANZapine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314154 | OLANZapine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314154 | OLANZapine 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314155 | OLANZapine 5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314155 | OLANZapine 5 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314155 | OLANZapine 5 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314155 | OLANZapine 5 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314155 | OLANZapine 5 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314157 | oseltamivir 60 MG per 5 ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 314157 | oseltamivir 60 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314157 | oseltamivir 60 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314157 | oseltamivir 60 MG per 5 ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 314160 | pentaerythritol tetranitrate 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314160 | pentaerythritol tetranitrate 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314163 | potassium chloride 8 MEQ Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314164 | procyclidine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314164 | procyclidine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314164 | procyclidine HCl 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314164 | procyclidine HCl 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314165 | prednisoLONE sodium phosphate 1 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314167 | procarbazine HCl 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314167 | procarbazine HCl 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314167 | procarbazine HCl 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314167 | procarbazine HCl 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314168 | prochlorperazine maleate 10 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314168 | prochlorperazine maleate 10 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314168 | prochlorperazine maleate 10 MG Extended Release Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 314168 | prochlorperazine maleate 10 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314168 | prochlorperazine maleate 10 MG Extended Release Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 314171 | pentaerythritol tetranitrate 60 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314171 | pentaerythritol tetranitrate 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314173 | amylase 8120 UNT / lipase 650 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314174 | phensuximide 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314174 | phensuximide 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314182 | potassium chloride 40 MEQ in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314184 | paromomycin sulfate 250 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314184 | paromomycin sulfate 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314184 | paromomycin sulfate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314184 | paromomycin sulfate 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314184 | paromomycin sulfate 250 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314188 | povidone-iodine 7.5 % Topical Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314188 | povidone-iodine 7.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314188 | povidone-iodine 7.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314188 | povidone-iodine 7.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314188 | povidone-iodine 7.5 % Topical Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314192 | prochlorperazine 10 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314192 | prochlorperazine 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314192 | prochlorperazine 10 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314192 | prochlorperazine 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314197 | palivizumab 50 MG per 0.5 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314197 | palivizumab 50 MG per 0.5 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314198 | polyvinyl alcohol 5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314198 | polyvinyl alcohol 5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3142 | dehydroemetine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314200 | pantoprazole sodium 40 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314203 | quinapril HCl 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314203 | quinapril HCl 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314203 | quinapril HCl 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314203 | quinapril HCl 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314203 | quinapril HCl 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314208 | rOPINIRole HCl 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314209 | rizatriptan benzoate 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314209 | rizatriptan benzoate 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314209 | rizatriptan benzoate 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314209 | rizatriptan benzoate 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314209 | rizatriptan benzoate 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314210 | rofecoxib 25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314210 | rofecoxib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314210 | rofecoxib 25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314210 | rofecoxib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314211 | risperiDONE 4 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314211 | risperiDONE 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314211 | risperiDONE 4 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314211 | risperiDONE 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314211 | risperiDONE 4 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314214 | rivastigmine tartrate 1.5 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314214 | rivastigmine tartrate 1.5 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314214 | rivastigmine tartrate 1.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314214 | rivastigmine tartrate 1.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314214 | rivastigmine tartrate 1.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314215 | rivastigmine tartrate 4.5 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314215 | rivastigmine tartrate 4.5 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314215 | rivastigmine tartrate 4.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314215 | rivastigmine tartrate 4.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314215 | rivastigmine tartrate 4.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314216 | simethicone 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314216 | simethicone 80 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314221 | simethicone 125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314221 | simethicone 125 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Full form of descriptor (FN) | YES | |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 314227 | SUMAtriptan 20 MG/ACTUAT Nasal Spray | Designated preferred name (PT) | YES | |
| RxCUI: 314228 | sildenafil citrate 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314228 | sildenafil citrate 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314228 | sildenafil citrate 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314228 | sildenafil citrate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314228 | sildenafil citrate 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314229 | sildenafil citrate 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314229 | sildenafil citrate 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314229 | sildenafil citrate 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314229 | sildenafil citrate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314229 | sildenafil citrate 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314230 | sirolimus 1 MG in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314230 | sirolimus 1 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314230 | sirolimus 1 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314230 | sirolimus 1 MG in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314230 | sirolimus 1 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314231 | simvastatin 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314231 | simvastatin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314231 | simvastatin 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314231 | simvastatin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314232 | somatropin 19 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314234 | sucralfate 1 GM Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314234 | sucralfate 1 GM Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314234 | sucralfate 1 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314234 | sucralfate 1 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314234 | sucralfate 1 GM Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314235 | triethanolamine polypeptide oleate condensate 10 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314235 | triethanolamine polypeptide oleate condensate 10 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314235 | triethanolamine polypeptide oleate condensate 10 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314236 | triflupromazine 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314236 | triflupromazine 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314237 | trimeprazine 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314237 | trimeprazine 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314238 | tropicamide 1 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314238 | tropicamide 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314238 | tropicamide 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314238 | tropicamide 1 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314238 | tropicamide 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314240 | theophylline 250 MG Extended Release Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 314240 | theophylline 250 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314240 | theophylline 250 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314240 | theophylline 250 MG Extended Release Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 314241 | theophylline 450 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314241 | theophylline 450 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314242 | thiamine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314242 | thiamine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314242 | thiamine 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314242 | thiamine 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314243 | thyroglobulin 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314243 | thyroglobulin 65 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314244 | tolazoline HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314244 | tolazoline HCl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314248 | tridihexethyl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314248 | tridihexethyl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314249 | tyrosine 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314249 | tyrosine 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314251 | theophylline 125 MG Extended Release Oral Capsule [Aerolate JR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314251 | theophylline 125 MG Extended Release Oral Capsule [Aerolate JR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 314253 | triazolam 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314253 | triazolam 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314256 | trifluoperazine 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314258 | thiopental 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314259 | Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 314259 | Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314259 | Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Full form of descriptor (FN) | YES | |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314266 | tacrolimus 0.1 % Topical Ointment | Designated preferred name (PT) | YES | |
| RxCUI: 314267 | thyroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314267 | thyroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314267 | thyroid 15 MG (1/4 grain) Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314267 | thyroid 15 MG (1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314268 | tazarotene 0.05 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 314268 | tazarotene 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314268 | tazarotene 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314268 | tazarotene 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314268 | tazarotene 0.05 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 314271 | unoprostone isopropyl 0.15 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314271 | unoprostone isopropyl 0.15 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314271 | unoprostone isopropyl 0.15 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 314271 | unoprostone isopropyl 0.15 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314271 | unoprostone isopropyl 0.15 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 314277 | venlafaxine HCl 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 314277 | venlafaxine HCl 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 314277 | venlafaxine HCl 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314277 | venlafaxine HCl 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314277 | venlafaxine HCl 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314285 | zonisamide 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314285 | zonisamide 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314285 | zonisamide 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314285 | zonisamide 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314286 | ziprasidone HCl 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 314286 | ziprasidone HCl 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314286 | ziprasidone HCl 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 314286 | ziprasidone HCl 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314286 | ziprasidone HCl 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314293 | acetylsalicylate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314298 | adrenocorticotropin (ACTH 1-18),I-125 (TYR) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314299 | Chromium (51-Cr) albumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314299 | Chromium (51-Cr) albumin | Designated preferred name (PT) | NO | |
| RxCUI: 314299 | Chromium (51-Cr) albumin | Full form of descriptor (FN) | NO | |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Designated preferred name (PT) | YES | |
| RxCUI: 3143 | Prasterone | Full form of descriptor (FN) | YES | |
| RxCUI: 3143 | Prasterone | Designated preferred name (PT) | YES | |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3143 | Prasterone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3143 | Prasterone | Full form of descriptor (FN) | YES | |
| RxCUI: 314301 | Iodinated (131-I) albumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314301 | Iodinated (131-I) albumin | Designated preferred name (PT) | YES | |
| RxCUI: 314301 | Iodinated (131-I) albumin | Full form of descriptor (FN) | YES | |
| RxCUI: 314302 | albumin,microsphere human serum | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314324 | Aspergillus terreus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31435 | valrubicin | Full form of descriptor (FN) | YES | |
| RxCUI: 31435 | valrubicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31435 | valrubicin | Designated preferred name (PT) | YES | |
| RxCUI: 31435 | valrubicin | Full form of descriptor (FN) | YES | |
| RxCUI: 31435 | valrubicin | Designated preferred name (PT) | YES | |
| RxCUI: 314365 | allergenic extract, false ragweed pollen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314411 | Monilia sitophila allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314411 | Monilia sitophila allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314411 | Monilia sitophila allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314415 | Mucor plumbeus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314428 | allergenic extract, pigweed, spiny, pollen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314443 | Rhizopus arrhizus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314455 | Bombyx mori fiber allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314455 | Bombyx mori fiber allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31447 | nabilone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31447 | nabilone | Designated preferred name (PT) | YES | |
| RxCUI: 31447 | nabilone | Full form of descriptor (FN) | YES | |
| RxCUI: 31447 | nabilone | Designated preferred name (PT) | YES | |
| RxCUI: 31447 | nabilone | Full form of descriptor (FN) | YES | |
| RxCUI: 314470 | walnut allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31448 | nabumetone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31448 | nabumetone | Designated preferred name (PT) | YES | |
| RxCUI: 31448 | nabumetone | Full form of descriptor (FN) | YES | |
| RxCUI: 31448 | nabumetone | Designated preferred name (PT) | YES | |
| RxCUI: 31448 | nabumetone | Full form of descriptor (FN) | YES | |
| RxCUI: 314488 | Ustilago maydis allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314488 | Ustilago maydis allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314493 | ammonium phosphate,monobasic | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314494 | ammonium silicofluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314495 | Amodiaquine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314495 | Amodiaquine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 314495 | Amodiaquine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Designated preferred name (PT) | YES | |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Full form of descriptor (FN) | YES | |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Designated preferred name (PT) | YES | |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314504 | Factor VIII inhibitor bypassing fraction | Full form of descriptor (FN) | YES | |
| RxCUI: 314506 | apiole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31451 | DPN kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31451 | DPN kinase | Designated preferred name (PT) | NO | |
| RxCUI: 31451 | DPN kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31451 | DPN kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 314513 | BCG, live, Montreal strain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314517 | belladonna leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314518 | Benactyzine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314518 | Benactyzine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 314518 | Benactyzine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 31452 | Nicotinamide adenine dinucleotide ^+^ pyrophosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 31452 | Nicotinamide adenine dinucleotide ^+^ pyrophosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31452 | Nicotinamide adenine dinucleotide ^+^ pyrophosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 314521 | benzoxiquine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31453 | NAD^+^ synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 31453 | NAD^+^ synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31453 | NAD^+^ synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31453 | NAD^+^ synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 314532 | Antigen of Candida | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314532 | Antigen of Candida | Full form of descriptor (FN) | NO | |
| RxCUI: 314532 | Antigen of Candida | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314532 | Antigen of Candida | Designated preferred name (PT) | NO | |
| RxCUI: 31454 | Nicotinamide adenine dinucleotide (phosphate) (NAD(P))^+^ nucleosidase | Designated preferred name (PT) | NO | |
| RxCUI: 31454 | Nicotinamide adenine dinucleotide (phosphate) (NAD(P))^+^ nucleosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31454 | Nicotinamide adenine dinucleotide (phosphate) (NAD(P))^+^ nucleosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31454 | Nicotinamide adenine dinucleotide (phosphate) (NAD(P))^+^ nucleosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 314540 | Cefaclor monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 314540 | Cefaclor monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 314546 | cerium oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314553 | chloride hexahydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314557 | cinnamedrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 31456 | Reduced nicotinamide adenine dinucleotide peroxidase | Designated preferred name (PT) | NO | |
| RxCUI: 31456 | Reduced nicotinamide adenine dinucleotide peroxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31456 | Reduced nicotinamide adenine dinucleotide peroxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 31457 | Reduced nicotinamide adenine dinucleotide dehydrogenase (quinone) | Designated preferred name (PT) | NO | |
| RxCUI: 31457 | Reduced nicotinamide adenine dinucleotide dehydrogenase (quinone) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31457 | Reduced nicotinamide adenine dinucleotide dehydrogenase (quinone) | Full form of descriptor (FN) | NO | |
| RxCUI: 314574 | Cysteine hydrochloride monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314574 | Cysteine hydrochloride monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314583 | D-biotin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314584 | D-glucuronic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314592 | Diltiazem maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314592 | Diltiazem maleate | Designated preferred name (PT) | NO | |
| RxCUI: 314592 | Diltiazem maleate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314592 | Diltiazem maleate | Full form of descriptor (FN) | NO | |
| RxCUI: 314596 | Dipropylene glycol salicylate | Designated preferred name (PT) | NO | |
| RxCUI: 314596 | Dipropylene glycol salicylate | Full form of descriptor (FN) | NO | |
| RxCUI: 314599 | disofenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3146 | Delsym | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 314605 | egg phospholipids | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314605 | egg phospholipids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314610 | racepinephrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314611 | ethyl dihydroxypropyl PABA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31462 | nadoxolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314623 | fibrinogen (125I) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314623 | fibrinogen (125I) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314633 | fomivirsen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314633 | fomivirsen sodium | Designated preferred name (PT) | NO | |
| RxCUI: 314633 | fomivirsen sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 314636 | formaldehyde solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314636 | formaldehyde solution | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314636 | formaldehyde solution | Designated preferred name (PT) | NO | |
| RxCUI: 314636 | formaldehyde solution | Full form of descriptor (FN) | NO | |
| RxCUI: 314637 | Foscarnet sodium hexahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 314637 | Foscarnet sodium hexahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 314639 | gallium chloride,Ga-67 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314642 | Absorbable gelatin film | Designated preferred name (PT) | NO | |
| RxCUI: 314642 | Absorbable gelatin film | Full form of descriptor (FN) | NO | |
| RxCUI: 314643 | Gelsemium extract | Designated preferred name (PT) | NO | |
| RxCUI: 314643 | Gelsemium extract | Full form of descriptor (FN) | NO | |
| RxCUI: 314647 | glyceryl monolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31465 | Reduced nicotinamide adenine dinucleotide phosphate peroxidase | Designated preferred name (PT) | NO | |
| RxCUI: 31465 | Reduced nicotinamide adenine dinucleotide phosphate peroxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31465 | Reduced nicotinamide adenine dinucleotide phosphate peroxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 314656 | Hemophilus B polysaccharide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314659 | heparin sodium, porcine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314659 | heparin sodium, porcine | Designated preferred name (PT) | YES | |
| RxCUI: 314659 | heparin sodium, porcine | Full form of descriptor (FN) | YES | |
| RxCUI: 314661 | hesperidin complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314666 | Hydrastis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314667 | hydrocodone resin complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314667 | hydrocodone resin complex | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314674 | Hyoscyamus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314682 | lente insulin, beef-pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314683 | Lente human insulin | Designated preferred name (PT) | NO | |
| RxCUI: 314683 | Lente human insulin | Full form of descriptor (FN) | NO | |
| RxCUI: 314683 | Lente human insulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314684 | Insulin lispro protamine crystallised | Designated preferred name (PT) | YES | |
| RxCUI: 314684 | Insulin lispro protamine crystallised | Full form of descriptor (FN) | YES | |
| RxCUI: 314684 | Insulin lispro protamine crystallised | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314684 | Insulin lispro protamine crystallised | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314684 | Insulin lispro protamine crystallised | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314685 | insulin, protamine zinc, beef-pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314686 | insulin, regular, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314687 | interferon alfa-3n,human leukocyte derived | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314691 | iodohippurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314705 | lanolin / petrolatum | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 314709 | L-ornithine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314709 | L-ornithine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314712 | Lilium longiflorium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314718 | magnesium acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314724 | meningococcal polysaccharide vaccine group W-135 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314725 | meningococcal polysaccharide vaccine group Y | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314726 | menthol / phenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 314731 | Metipranolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314731 | Metipranolol hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 314731 | Metipranolol hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 314743 | nux vomica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31475 | naftazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314753 | orris allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 31476 | Naftifine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31476 | Naftifine | Designated preferred name (PT) | YES | |
| RxCUI: 31476 | Naftifine | Full form of descriptor (FN) | YES | |
| RxCUI: 31476 | Naftifine | Designated preferred name (PT) | YES | |
| RxCUI: 31476 | Naftifine | Full form of descriptor (FN) | YES | |
| RxCUI: 314774 | pentetate pentasodium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314776 | peptone,dried | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314784 | Yellow phenolphthalein | Full form of descriptor (FN) | NO | |
| RxCUI: 314784 | Yellow phenolphthalein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314784 | Yellow phenolphthalein | Designated preferred name (PT) | NO | |
| RxCUI: 314784 | Yellow phenolphthalein | Full form of descriptor (FN) | NO | |
| RxCUI: 314784 | Yellow phenolphthalein | Designated preferred name (PT) | NO | |
| RxCUI: 314786 | phenyltoloxamine resin complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 31479 | nalmefene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31479 | nalmefene | Designated preferred name (PT) | YES | |
| RxCUI: 31479 | nalmefene | Full form of descriptor (FN) | YES | |
| RxCUI: 31479 | nalmefene | Designated preferred name (PT) | YES | |
| RxCUI: 31479 | nalmefene | Full form of descriptor (FN) | YES | |
| RxCUI: 314797 | potassium lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314809 | Psyllium mucilloid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314809 | Psyllium mucilloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314812 | psyllium seed coatings,blond | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314826 | colloidal silicon dioxide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314826 | colloidal silicon dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314832 | sodium lauryl sulfoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314837 | Sodium phosphate dihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314837 | Sodium phosphate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314837 | Sodium phosphate dihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314838 | sodium phosphate, dibasic, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314845 | somatropin (recombinant DNA origin) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314853 | stannous chloride,anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 314874 | thiobutabarbital sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 314875 | tocopheryl acid succinate,D-alpha | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 314881 | undecylenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314896 | wheat germ preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 314903 | APAP 150 MG / Caffeine 30 MG / Codeine 8 MG / salicylamide 230 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314903 | APAP 150 MG / Caffeine 30 MG / Codeine 8 MG / salicylamide 230 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314905 | APAP 300 MG / Codeine 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314905 | APAP 300 MG / Codeine 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314908 | APAP 325 MG / butalbital 50 MG / Codeine 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314908 | APAP 325 MG / butalbital 50 MG / Codeine 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314929 | chlorpheniramine maleate 0.8 MG/mL / ePHEDrine HCl 1.64 MG/mL / guaiFENesin 20 MG/mL / hydroiodic acid 0.334 mL/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314929 | chlorpheniramine maleate 0.8 MG/mL / ePHEDrine HCl 1.64 MG/mL / guaiFENesin 20 MG/mL / hydroiodic acid 0.334 mL/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314929 | chlorpheniramine maleate 0.8 MG/mL / ePHEDrine HCl 1.64 MG/mL / guaiFENesin 20 MG/mL / hydroiodic acid 0.334 mL/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314929 | chlorpheniramine maleate 0.8 MG/mL / ePHEDrine HCl 1.64 MG/mL / guaiFENesin 20 MG/mL / hydroiodic acid 0.334 mL/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314929 | chlorpheniramine maleate 0.8 MG/mL / ePHEDrine HCl 1.64 MG/mL / guaiFENesin 20 MG/mL / hydroiodic acid 0.334 mL/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 314933 | benzocaine 63 MG/ML / phenol 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314935 | povidone-iodine 0.5 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314935 | povidone-iodine 0.5 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314935 | povidone-iodine 0.5 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 31494 | nandrolone decanoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 31494 | nandrolone decanoate | Designated preferred name (PT) | NO | |
| RxCUI: 31494 | nandrolone decanoate | Full form of descriptor (FN) | NO | |
| RxCUI: 314941 | Alternaria alternata allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314941 | Alternaria alternata allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314941 | Alternaria alternata allergenic extract 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 314941 | Alternaria alternata allergenic extract 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 314941 | Alternaria alternata allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 314945 | corn allergenic extract 10,000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314945 | corn allergenic extract 10,000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 31495 | nandrolone phenpropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 31495 | nandrolone phenpropionate | Designated preferred name (PT) | NO | |
| RxCUI: 31495 | nandrolone phenpropionate | Full form of descriptor (FN) | NO | |
| RxCUI: 314965 | lipase 5000 UNT / amylase 20,000 UNT / protease 20,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314965 | lipase 5000 UNT / amylase 20,000 UNT / protease 20,000 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314965 | lipase 5000 UNT / amylase 20,000 UNT / protease 20,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314965 | lipase 5000 UNT / amylase 20,000 UNT / protease 20,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314973 | ferrous fumarate 200 MG (iron 66 MG) / vitamin C 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314973 | ferrous fumarate 200 MG (iron 66 MG) / vitamin C 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314973 | ferrous fumarate 200 MG (iron 66 MG) / vitamin C 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314973 | ferrous fumarate 200 MG (iron 66 MG) / vitamin C 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314974 | vit-C 150 MG / Ferrous fumarate 75 MG / folate 1 MG / Intrinsic factor 0.015 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314974 | vit-C 150 MG / Ferrous fumarate 75 MG / folate 1 MG / Intrinsic factor 0.015 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314974 | vit-C 150 MG / Ferrous fumarate 75 MG / folate 1 MG / Intrinsic factor 0.015 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314982 | ferrous fumarate 200 MG / ascorbic acid 60 MG / vitamin B12 5 MCG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314982 | ferrous fumarate 200 MG / ascorbic acid 60 MG / vitamin B12 5 MCG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314982 | ferrous fumarate 200 MG / ascorbic acid 60 MG / vitamin B12 5 MCG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 314982 | ferrous fumarate 200 MG / ascorbic acid 60 MG / vitamin B12 5 MCG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314982 | ferrous fumarate 200 MG / ascorbic acid 60 MG / vitamin B12 5 MCG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314986 | ASA 200 MG / butalbital 50 MG / Caffeine 40 MG / Codeine 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314986 | ASA 200 MG / butalbital 50 MG / Caffeine 40 MG / Codeine 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314988 | ASA 380 MG / Caffeine 30 MG / Codeine 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 314988 | ASA 380 MG / Caffeine 30 MG / Codeine 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 314994 | bacitracin 0.4 UNT/MG / diperodon 0.01 MG/MG / neomycin 0.005 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |